Skip to main navigation Skip to search Skip to main content

Prognostic and Predictive Biomarkers in Recurrent WHO Grade 3 Malignant Glioma Patients Treated with Bevacizumab and Irinotecan

  • Helle Broholm (Lecturer)

Activity: Talk or presentation › Lecture and oral contribution

Period19 May 2016 → 21 May 2016
Event titleThe Scandinavian Society of Neuro-Oncology: Meeting 2016
Event typeConference
LocationCopenhagen, DenmarkShow on map
Degree of RecognitionInternational